{"id":55809,"date":"2023-04-13T22:04:13","date_gmt":"2023-04-13T20:04:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/"},"modified":"2023-04-13T22:04:13","modified_gmt":"2023-04-13T20:04:13","slug":"qnovia-to-present-at-gilmartin-group-private-company-showcase","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/","title":{"rendered":"Qnovia to Present at Gilmartin Group Private Company Showcase"},"content":{"rendered":"
\n

RICHMOND, Va.–(BUSINESS WIRE)–Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today that Brian Quigley, CEO, will give a corporate presentation at Gilmartin Group\u2019s inaugural virtual Spring Private Company Showcase. The company will present on Tuesday, April 18, 2023, at 4:00pm ET.<\/p>\n

<\/a><\/p>\n

\nTo attend the presentation, please register using this link<\/a>.<\/p>\n

\nAbout Qnovia, Inc.<\/b><\/p>\n

\nQnovia, Inc., formerly Respira Technologies, Inc., is a pharma company focused on developing and commercializing proprietary inhalation device technologies to improve patient outcomes. The company\u2019s drug delivery platform is the first orientation-agnostic, portable vibrating mesh nebulizer that effectively operates in any position held by the patient. Qnovia sees significant opportunity to utilize its drug delivery technologies to improve the treatment of asthma, COPD, vaccine delivery, pain management, and several generic as well as select investigational new drugs. The company was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies. The company can be found at www.qnovia.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations:<\/b>
Kiki Patel, PharmD
\n
Gilmartin Group, Principal
\n
Kiki@gilmartinir.com<\/a><\/p>\n

Media Relations:<\/b>
Richard Laermer
\n
CEO
\n
RLM Public Relations
\n
212-741-5106 X 216
\n
Qnovia@RLMpr.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

RICHMOND, Va.–(BUSINESS WIRE)–Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today that Brian Quigley, CEO, will give a corporate presentation at Gilmartin Group\u2019s inaugural virtual Spring Private Company Showcase. The company will present on Tuesday, April 18, 2023, at 4:00pm ET. To attend the presentation, please register using … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55809","6":"format-standard","7":"category-industry"},"yoast_head":"\nQnovia to Present at Gilmartin Group Private Company Showcase - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qnovia to Present at Gilmartin Group Private Company Showcase - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"RICHMOND, Va.–(BUSINESS WIRE)–Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today that Brian Quigley, CEO, will give a corporate presentation at Gilmartin Group\u2019s inaugural virtual Spring Private Company Showcase. The company will present on Tuesday, April 18, 2023, at 4:00pm ET. To attend the presentation, please register using ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-13T20:04:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230413005802\/en\/1763604\/21\/Qnovia.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-to-present-at-gilmartin-group-private-company-showcase\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-to-present-at-gilmartin-group-private-company-showcase\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Qnovia to Present at Gilmartin Group Private Company Showcase\",\"datePublished\":\"2023-04-13T20:04:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-to-present-at-gilmartin-group-private-company-showcase\\\/\"},\"wordCount\":206,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-to-present-at-gilmartin-group-private-company-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005802\\\/en\\\/1763604\\\/21\\\/Qnovia.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-to-present-at-gilmartin-group-private-company-showcase\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-to-present-at-gilmartin-group-private-company-showcase\\\/\",\"name\":\"Qnovia to Present at Gilmartin Group Private Company Showcase - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-to-present-at-gilmartin-group-private-company-showcase\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-to-present-at-gilmartin-group-private-company-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005802\\\/en\\\/1763604\\\/21\\\/Qnovia.jpg\",\"datePublished\":\"2023-04-13T20:04:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-to-present-at-gilmartin-group-private-company-showcase\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-to-present-at-gilmartin-group-private-company-showcase\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-to-present-at-gilmartin-group-private-company-showcase\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005802\\\/en\\\/1763604\\\/21\\\/Qnovia.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005802\\\/en\\\/1763604\\\/21\\\/Qnovia.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qnovia-to-present-at-gilmartin-group-private-company-showcase\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Qnovia to Present at Gilmartin Group Private Company Showcase\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Qnovia to Present at Gilmartin Group Private Company Showcase - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/","og_locale":"en_US","og_type":"article","og_title":"Qnovia to Present at Gilmartin Group Private Company Showcase - Pharma Trend","og_description":"RICHMOND, Va.–(BUSINESS WIRE)–Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today that Brian Quigley, CEO, will give a corporate presentation at Gilmartin Group\u2019s inaugural virtual Spring Private Company Showcase. The company will present on Tuesday, April 18, 2023, at 4:00pm ET. To attend the presentation, please register using ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-13T20:04:13+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230413005802\/en\/1763604\/21\/Qnovia.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Qnovia to Present at Gilmartin Group Private Company Showcase","datePublished":"2023-04-13T20:04:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/"},"wordCount":206,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230413005802\/en\/1763604\/21\/Qnovia.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/","url":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/","name":"Qnovia to Present at Gilmartin Group Private Company Showcase - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230413005802\/en\/1763604\/21\/Qnovia.jpg","datePublished":"2023-04-13T20:04:13+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230413005802\/en\/1763604\/21\/Qnovia.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230413005802\/en\/1763604\/21\/Qnovia.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/qnovia-to-present-at-gilmartin-group-private-company-showcase\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Qnovia to Present at Gilmartin Group Private Company Showcase"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55809"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55809\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}